BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.
Abdalian most recently was VP and CFO at Knome, and he has been CEO at Pelias Technologies and CFO at Molecular Insight Pharmaceutical Group and Emisphere Technologies.
Caprotec Bioanalytics has appointed Jonathan Turner to be CEO and managing director. Turner will take over the CEO spot from company founder Hubert Koester, who will continue to work with the company as acting chief scientific officer and chairman of the scientific advisory board.
Turner formerly was senior vice president at XL Techgroup, a technology developer and equity firm, and he held senior management posts at Boehringer Ingelheim, AstraZeneca, and Schering.
Aushon Biosystems this week appointed Bill Williams vice president of sales.
Williams was previously founder and owner of the life sciences market research firm Web Prospects. Before that he was US national sales manager for Ciphergen Biosystems.